Article thumbnail

Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media

By Kyung-Jin Min, Kyeong A So, Jieun Lee, Hye-Ri Hong, Jin-Hwa Hong, Jae-Kwan Lee and Ae-Ree Kim
Topics: Original Article
Publisher: Korean Society of Gynecologic Oncology and Colposcopy
OAI identifier: oai:pubmedcentral.nih.gov:3280067
Provided by: PubMed Central

Suggested articles

Citations

  1. Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multicenter study.
  2. (2005). Carcinogenicity of human papillo maviruses. Lancet Oncol
  3. Chapter 2: Natural history of anoge nital human papillomavirus infection and neoplasia.
  4. Clinical performance of the PreTect HPVProofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
  5. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 highrisk human papillomavirus infections.
  6. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquidbased cytology: use of INNOLiPA Genotyping assay to screen the discordant results.
  7. Comparison of the novel human papillomavirus 4 autocapillary elec tro phoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of highrisk HPV including HPV 16 and 18 genotypes in cervical specimens.
  8. Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high risk HPV DNA.
  9. (2007). Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene.
  10. Epidemiology and natural history of human papillomavirus infections and typespecific implications in cervical neoplasia.
  11. (2007). Human papillomavirus and cervical cancer. Lancet
  12. Human papillomavirus types in invasive cervical cancer worldwide: a metaanalysis.
  13. Populationbased study of human pa pil lomavirus infection and cervical neoplasia in rural Costa Rica.
  14. (2005). The elevated 10year risk of cervical pre cancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of typespe ci fic HPV testing in clinical practice.
  15. Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.